Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.20B
Revenue (ttm)	900.68M
Net Income (ttm)	83.50M
Shares Out	961.94M
EPS (ttm)	0.09
PE Ratio	14.39
Forward PE	12.08
Dividend	0.03 (2.42%)
Ex-Dividend Date	Sep 8, 2025

Volume	357,600
Average Volume	428,325
Open	1.250
Previous Close	1.250
Day's Range	1.250 - 1.280
52-Week Range	1.070 - 1.460
Beta	0.22
RSI	45.19
Earnings Date	Feb 19, 2026

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.